Chelsea Football Club has a long history of pioneering initiatives, and its latest effort focuses on the health and well‑being of its women’s team. While many of the club’s first‑ever achievements have been celebrated on the pitch, this time the breakthrough comes behind the scenes, where the Blues have introduced a comprehensive fertility and maternity programme that gives players the freedom to start families on their own terms while still competing at the highest level.
In a historic move, Chelsea became the first club in the Women’s Super League to roll out a dedicated fertility and maternity policy. The framework offers players a range of options—from egg freezing and in‑vitro fertilisation (IVF) to routine smear tests and contraception—backed by a financial fund managed in partnership with Fertility Plus, one of London’s leading fertility clinics. The aim is to provide every squad member with the knowledge, resources and professional support needed to make informed decisions about their reproductive health without feeling pressured either way.
The partnership with Fertility Plus goes beyond simply covering medical costs. It includes counselling sessions, educational workshops and personalised guidance on hormone management, endometriosis, cycle tracking and other aspects of female health that can affect performance. Players can access these services voluntarily, and the club has stressed that the programme is not mandatory; it is a supportive safety net that can be used whenever an individual feels it is appropriate.
Chelsea’s Player Maternity Policy is equally extensive. It outlines personalised care throughout pregnancy and the post‑natal period, financial assistance for a partner or nanny to travel with the player to away fixtures for up to a year after her return, and enhanced adoption and parental‑leave provisions.
In addition, the club offers wage protection and subsidised childcare, ensuring that returning mothers do not face a financial penalty for choosing to have children. Head coach Sonia Bompastor explained the philosophy behind the policy in an exclusive interview with Sky Sports: “Our priority has always been to support our players in the best possible way. We want them to have full knowledge of the options available, so they can make the choices that suit their personal and professional lives. No one should have to pick between a football career and motherhood—both can now coexist.” Former goalkeeper and current commercial manager Carly Telford was instrumental in shaping the collaboration with Fertility Plus.
She told Sky Sports that she had witnessed the challenges female athletes face when navigating fertility decisions and wanted Chelsea to lead the way. “We needed a clinic that understood us as athletes first and as women second, offering more than just egg freezing. The goal was an all‑encompassing service covering hormones, cycle tracking, testing and any condition that impacts the female body,” she said.
“The ultimate decision remains with the player, but having those options available changes the conversation entirely.” Bompastor’s own experience underscores the importance of the new framework. She is a mother of four with partner and Chelsea assistant coach Camille Abily. During her playing days, limited options forced her to retire earlier than she might have otherwise, as she struggled to reconcile the demands of elite sport with the desire to start a family.
“At the time I didn’t have a real choice,” she recalled. “I had to decide between a longer playing career and becoming a mother, and the lack of support made the decision far more difficult.” The club’s commitment to transparency and privacy is also evident.
No player has publicly announced plans to use the new resources, and Chelsea stresses that any personal medical information will remain confidential between the player, the club’s medical staff and Fertility Plus. Telford, who maintains close relationships with many squad members, reported overwhelmingly positive feedback when the programme was introduced.
“Players have told us they feel reassured and empowered. They appreciate that the club is proactively addressing a topic that was previously hidden,” she said. Chelsea is not starting from scratch when it comes to supporting pregnant athletes. Midfielder Melanie Leupolz gave birth in 2022 and returned to the first team, while Zecira Musovic took maternity leave in 2025 before re‑joining the squad.
More recently, former captain Millie Bright announced her pregnancy after retiring, highlighting the relevance of fertility discussions for players in their thirties who may be contemplating life after football. The dual programmes—fertility support and maternity care—work in tandem to give each player a clear pathway, whether she wishes to conceive now, freeze her eggs for later, or simply maintain optimal gynecological health. Bompastor summed up the broader impact: “Being a mother is something you learn by living it. Providing information, sharing experiences and offering concrete support allows our athletes to thrive both on the pitch and at home.” Beyond the immediate benefits for Chelsea’s squad, Telford hopes the initiative will spark a wider conversation about women’s health in sport.
She believes the club’s global platform can influence other football organisations, governing bodies and even businesses to rethink how they support female athletes. “We are one of the biggest brands in the world. If we can demonstrate a model that respects women’s bodies and offers real choices, we can encourage others to follow suit,” she said.
The overarching message is clear: Chelsea is setting a new benchmark for how professional clubs can treat their female players as whole people, not just performers. By integrating medical expertise, financial backing and a culture of openness, the club is ensuring that future generations of footballers will no longer have to sacrifice motherhood for sport—or vice‑versa.
This forward‑thinking approach not only enhances player welfare but also positions Chelsea as a leader in the ongoing evolution of women’s football and women’s health worldwide.